Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Nutt D.

125 indexed publications match this author name.

ORCID
0000-0002-1286-1401
OpenAlex
https://openalex.org/A5016082897

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01The Australia story: Current status and future challenges for the clinical applications of psychedelics.British journal of pharmacology · 2026-07-01Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitaloprambioRxiv · 2026-06-26Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment OutcomesResearch Square · 2026-06-19Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation TheorembioRxiv · 2026-06-16Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-06-01Exploring new avenues: Psychedelic-assisted therapy for young people.British journal of clinical pharmacology · 2026-05-08Human brain changes after first psilocybin useNature Communications · 2026-05-05An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.Translational psychiatry · 2025-11-13Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.Comprehensive psychiatry · 2025-10-01A lexicon for psychedelic research and treatmentDrug Science Policy and Law · 2025-08-31Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed NeuroimagingbioRxiv · 2025-07-03Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.Neuroscience and biobehavioral reviews · 2025-05-01The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialmedRxiv · 2025-03-21Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depressionNeuroscience Applied · 2025-01-01Serotonergic psychedelics for depression: A comprehensive overview.International review of neurobiology · 2025-01-01Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.Frontiers in psychology · 2025-01-01Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-07Human brain changes after first psilocybin usebioRxiv · 2024-10-14Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.EClinicalMedicine · 2024-10-01A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-19Is it now time to prepare psychiatry for a psychedelic future?The British journal of psychiatry: the journal of mental science · 2024-08-01Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.Psychological medicine · 2024-06-01Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity.Journal of affective disorders · 2024-05-15Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.Journal of psychopharmacology (Oxford, England) · 2024-05-01Psychedelics: reconnecting the brain to heal the mindThe Biochemist · 2024-03-25Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-07Effects of DMT on mental health outcomes in healthy volunteers.Scientific reports · 2024-02-07Psychedelics and sexual functioning: a mixed-methods study.Scientific reports · 2024-02-07Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.Psychological medicine · 2024-01-01Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.Psychological medicine · 2024-01-01When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.Neuroethics · 2024-01-01Psilocybin and Other Classic Psychedelics in Depression.Current topics in behavioral neurosciences · 2024-01-01Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.European addiction research · 2024-01-01Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Neuroscience applied · 2024-01-01Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".Frontiers in psychiatry · 2024-01-01Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model.Psychological medicine · 2023-12-01Neuroimaging in psychedelic drug development: past, present, and future.Molecular psychiatry · 2023-09-01Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins.British journal of clinical pharmacology · 2023-09-01Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.Psychiatry research · 2023-09-01A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression.Journal of psychopharmacology (Oxford, England) · 2023-07-01Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depressionmedRxiv · 2023-06-03Psychedelic Medicine: From Brain Science to Clinical TrialsBiological Psychiatry · 2023-04-09Default Mode Network Modulation by Psychedelics: A Systematic Review.The international journal of neuropsychopharmacology · 2023-03-22Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic medicine (New Rochelle, N.Y.) · 2023-03-01Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2023-01-01Mescaline: The forgotten psychedelic.Neuropharmacology · 2023-01-01Body mass index (BMI) does not predict responses to psilocybin.Journal of psychopharmacology (Oxford, England) · 2023-01-01Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.Journal of psychopharmacology (Oxford, England) · 2023-01-01The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-11-01Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trialPsyArXiv · 2022-10-19Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.Nature communications · 2022-10-03Brain dynamics predictive of response to psilocybin for treatment-resistant depressionResearch Square · 2022-09-20Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych open · 2022-09-06Psychedelic PsychiatryEuropean psychiatry: the journal of the Association of European Psychiatrists · 2022-09-01Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.Journal of psychopharmacology (Oxford, England) · 2022-08-01Brain dynamics predictive of response to psilocybin for treatment-resistant depressionbioRxiv · 2022-07-04A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-07-01A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-07-01Neuroimaging in psychedelic drug development: Past, present, and futurePsyArXiv · 2022-06-30Neuroimaging in psychedelic drug development: Past, present, and futurePsyArXiv · 2022-06-30A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed MindsPsyArXiv · 2022-05-10A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed MindsPsyArXiv · 2022-05-10Increased global integration in the brain after psilocybin therapy for depression.Nature medicine · 2022-04-01Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.Journal of psychopharmacology (Oxford, England) · 2022-03-01Increased low-frequency brain responses to music after psilocybin therapy for depressionbioRxiv · 2022-02-15Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancerDrug Science Policy and Law · 2022-01-01Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.Network neuroscience (Cambridge, Mass.) · 2022-01-01P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-12-01P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to musicEuropean Neuropsychopharmacology · 2021-12-01Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online surveyPsychopharmacology · 2021-11-03Decreased brain modularity after psilocybin therapy for depression.Research Square · 2021-05-20LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theorybioRxiv · 2021-05-17Trial of Psilocybin versus Escitalopram for Depression.The New England journal of medicine · 2021-04-15Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.Acta psychiatrica Scandinavica · 2021-02-01Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in psychiatry · 2021-01-01Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in pharmacology · 2021-01-01Psychedelic Psychiatry's Brave New World.Cell · 2020-04-02Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2020-02-01Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017Drug Science Policy and Law · 2020-01-01P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depressionEuropean Neuropsychopharmacology · 2019-12-01Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.NeuroImage · 2019-10-15Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.NeuroImage · 2019-10-01Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.Journal of psychopharmacology (Oxford, England) · 2019-09-01Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.Acta neuropsychiatrica · 2019-08-01Psychedelic drugs-a new era in psychiatry?.Dialogues in clinical neuroscience · 2019-01-01Psychiatry & the psychedelic drugs. Past, present & future.Neuropharmacology · 2018-11-01Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.Neuropharmacology · 2018-11-01Effects of psilocybin therapy on personality structure.Acta psychiatrica Scandinavica · 2018-11-01Altered trajectories in the dynamical repertoire of functional network states under psilocybinbioRxiv · 2018-07-25Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.Scientific reports · 2018-05-29Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.Journal of affective disorders · 2018-04-01Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.Psychopharmacology · 2018-02-01Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2018-02-01The hidden therapist: evidence for a central role of music in psychedelic therapy.Psychopharmacology · 2018-02-01Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific reports · 2017-10-13Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant DepressionJournal of Humanistic Psychology · 2017-06-19Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.Frontiers in pharmacology · 2017-01-01Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.Journal of psychopharmacology (Oxford, England) · 2016-12-01Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol useCurrent Opinion in Behavioral Sciences · 2016-11-14Question-based Drug Development for psilocybin - Authors' reply.The lancet. Psychiatry · 2016-09-01Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The lancet. Psychiatry · 2016-07-01Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.Human brain mapping · 2015-08-015HT2a Receptors - a New Target for Depression?European Psychiatry · 2015-03-01Homological scaffolds of brain functional networks.Journal of the Royal Society, Interface · 2014-12-06Enhanced repertoire of brain dynamical states during the psychedelic experience.Human brain mapping · 2014-11-01A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.Current drug abuse reviews · 2014-01-01The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.Frontiers in human neuroscience · 2014-01-01The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.Frontiers in human neuroscience · 2014-01-01Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Schizophrenia bulletin · 2013-11-01Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.Journal of psychopharmacology (Oxford, England) · 2013-09-01Experienced drug users assess the relative harms and benefits of drugs: a web-based survey.Journal of psychoactive drugs · 2013-01-01Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.The British journal of psychiatry: the journal of mental science · 2012-03-01Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences of the United States of America · 2012-02-07The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.Journal of psychopharmacology (Oxford, England) · 2011-11-01P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybinEuropean Neuropsychopharmacology · 2011-08-07

Author directory

Robin Carhart-Harris176 publicationsDavid Nutt121 publicationsDavid Erritzøe84 publicationsFranz X. Vollenweider84 publicationsRoland R. Griffiths84 publicationsMatthew W. Johnson69 publicationsKatrin H. Preller64 publicationsFrederick S. Barrett60 publicationsGitte M. Knudsen57 publicationsLeor Roseman55 publicationsJames Rucker48 publicationsAlbert Garcia-Romeu46 publicationsTomáš Páleníček44 publicationsPatrick M. Fisher43 publicationsSandeep M. Nayak43 publicationsKim P. C. Kuypers42 publicationsDea Siggaard Stenbæk41 publicationsJoshua D. Rosenblat41 publicationsNatasha L. Mason39 publicationsPeter S. Hendricks37 publicationsAlan K. Davis35 publicationsChristopher Timmermann33 publicationsDavid Bryce Yaden33 publicationsMatthias E. Liechti33 publicationsMuhammad Ishrat Husain33 publicationsBrice Ozenne32 publicationsJohns Hopkins University31 publicationsGuy M. Goodwin30 publicationsHannes Kettner30 publicationsJohannes G. Ramaekers30 publicationsStephen Ross30 publicationsMichael P. Bogenschutz29 publicationsRoger S. McIntyre29 publicationsDirk Hoffmeister28 publicationsErich Seifritz27 publicationsRobert B. Kargbo27 publicationsRichard J. Zeifman26 publicationsBrian Anderson25 publicationsMartin Korsbak Madsen25 publicationsAllan H. Young24 publicationsCharles D. Nichols24 publicationsDrummond E-Wen McCulloch24 publicationsGabrielle Agin-Liebes24 publicationsJavier González-Maeso24 publicationsMartin Kuchař24 publicationsMorten L. Kringelbach24 publicationsNathan D. Sepeda24 publicationsNatalie Gukasyan23 publicationsPaul Liknaitzky23 publicationsXiaohui Wang23 publicationsFriederike Holze22 publicationsGustavo Deco22 publicationsScott Aaronson22 publicationsBrian S. Barnett21 publicationsBruna Giribaldi21 publicationsOlivia Carter21 publicationsOtto Simonsson21 publicationsRafael G. dos Santos21 publicationsAdam L. Halberstadt20 publicationsAlex Kwan20 publicationsManoj Doss20 publicationsMichael Kometer20 publicationsBenjamin Kelmendi19 publicationsBernard Lerer19 publicationsJacob S. Aday19 publicationsJaime E. C. Hallak19 publicationsJiřı́ Horáček19 publicationsMatthew B. Wall19 publicationsRoland A. Fischer19 publicationsRotem Petranker19 publicationsCharles L. Raison18 publicationsDavid E. Nichols18 publicationsEnzo Tagliazucchi18 publicationsMendel Kaelen18 publicationsRobert A. Schoevers18 publicationsAlexander M. Sherwood17 publicationsAmanda Feilding17 publicationsClaire J. Foldi17 publicationsDavid J. Hellerstein17 publicationsFelix Müller17 publicationsFernando Rosas17 publicationsFilip Tylš17 publicationsJeffrey Guss17 publicationsManish Agrawal17 publicationsMilan Scheidegger17 publicationsTomislav Majić17 publicationsWilliam A. Richards17 publicationsChristopher S. Stauffer16 publicationsKevin F. Boehnke16 publicationsMalievskaia E16 publicationsNadav Liam Modlin16 publicationsSophia Armand16 publicationsYale University16 publicationsCharles S. Grob15 publicationsEmmanuelle A. D. Schindler15 publicationsFelix Hasler15 publicationsGeyer MA15 publicationsJason B. Luoma15 publicationsKelly JR15 publicationsLea J. Mertens15 publicationsLindsey Marwood15 publicationsPablo Mallaroni15 publicationsSuresh Muthukumaraswamy15 publicationsTzuri Lifschytz15 publicationsUniversity Hospital15 publicationsAnna M. Becker14 publicationsBoadie W. Dunlop14 publicationsBrandon Weiss14 publicationsFederico Seragnoli14 publicationsGerhard Gründer14 publicationsHenrik Jungaberle14 publicationsJanis Fricke14 publicationsJeng-Yu Tsai14 publicationsJochen Gartz14 publicationsJoshua S. Siegel14 publicationsMeg J Spriggs14 publicationsMika Turkia14 publicationsNathalie M. Rieser14 publicationsRodrigo B. Mansur14 publicationsSusan L. Rossell14 publications